Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

This publication has 81 references indexed in Scilit:

• The Corticotropin-Releasing Factor1 Receptor Antagonist R121919 Attenuates the Behavioral and Endocrine Responses to Stress
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• Galanin GAL-R1 Receptor Null Mutant Mice Display Increased Anxiety-Like Behavior Specific to the Elevated Plus-Maze
  Neuropsychopharmacology, 2003
• Reduction of Hypothalamic Vasopressinergic Hyperdrive Contributes to Clinically Relevant Behavioral and Neuroendocrine Effects of Chronic Paroxetine Treatment in a Psychopathological Rat Model
  Neuropsychopharmacology, 2002
• The Neuropeptide Y (NPY) Y1 Receptor Subtype Mediates NPY-induced Antidepressant-like Activity in the Mouse Forced Swimming Test
  Neuropsychopharmacology, 2002
• Brain Neuropeptide Υ (NPY) in Stress and Alcohol Dependence
  Reviews in the Neurosciences, 2002
• Dose Response of Arginine Vasopressin to the CCK-B Agonist Pentagastrin
  Neuropsychopharmacology, 2001
• Anxiogenic-Like Action of Galanin after Intra-Amygdala Administration in the Rat
  Neuropsychopharmacology, 1999
• Substance P is involved in the sensitization of the acoustic startle response by footshocks in rats
  Behavioural Brain Research, 1994
• Coexistence of peptides and classical neurotransmitters
  Trends in Neurosciences, 1983
• Organization of Ovine Corticotropin-Releasing Factor Immunoreactive Cells and Fibers in the Rat Brain: An Immunohistochemical Study
  Neuroendocrinology, 1983